InnoCare Pharma Limited (9969.HK)

HKD 6.1

(0.16%)

Total Assets Summary of InnoCare Pharma Limited

InnoCare Pharma Limited's latest annual total assets in 2023 was 9.91 Billion CNY , down -3.9% from previous year.
InnoCare Pharma Limited's latest quarterly total assets in 2024 Q2 was 9.67 Billion CNY , down -0.92% from previous quarter.
InnoCare Pharma Limited reported annual total assets of 10.32 Billion CNY in 2022, up 39.52% from previous year.
InnoCare Pharma Limited reported annual total assets of 7.39 Billion CNY in 2021, up 63.02% from previous year.
InnoCare Pharma Limited reported quarterly total assets of 9.76 Billion CNY for 2024 Q1, down -1.54% from previous quarter.
InnoCare Pharma Limited reported quarterly total assets of 10.21 Billion CNY for 2023 Q1, down -1.02% from previous quarter.

Annual Total Assets Chart of InnoCare Pharma Limited (2023 - 2017)

Historical Annual Total Assets of InnoCare Pharma Limited (2023 - 2017)

Year	Total Assets	Total Assets Growth
2023	9.91 Billion CNY	-3.9%
2022	10.32 Billion CNY	39.52%
2021	7.39 Billion CNY	63.02%
2020	4.53 Billion CNY	73.48%
2019	2.61 Billion CNY	18.83%
2018	2.2 Billion CNY	1949.48%
2017	107.4 Million CNY	0.0%

Year	Total Assets	Total Assets Growth
2024 Q2	9.67 Billion CNY	-0.92%
2024 Q1	9.76 Billion CNY	-1.54%
2023 Q1	10.21 Billion CNY	-1.02%
2023 FY	9.91 Billion CNY	-3.9%
2023 Q3	10.03 Billion CNY	-1.48%
2023 Q2	10.19 Billion CNY	-0.25%
2023 Q4	9.91 Billion CNY	-1.2%
2022 Q4	10.32 Billion CNY	-1.06%
2022 Q3	10.43 Billion CNY	36.52%
2022 Q2	7.64 Billion CNY	0.0%
2022 Q1	- CNY	-100.0%
2022 FY	10.32 Billion CNY	39.52%
2021 Q4	7.39 Billion CNY	0.0%
2021 FY	7.39 Billion CNY	63.02%
2021 Q1	6.98 Billion CNY	53.87%
2021 Q2	6.98 Billion CNY	0.0%
2020 Q4	4.53 Billion CNY	0.0%
2020 Q2	4.8 Billion CNY	0.0%
2020 Q1	4.8 Billion CNY	83.68%
2020 FY	4.53 Billion CNY	73.48%
2020 Q3	4.53 Billion CNY	-5.55%
2019 Q1	2.53 Billion CNY	15.16%
2019 FY	2.61 Billion CNY	18.83%
2019 Q3	2.65 Billion CNY	4.77%
2019 Q2	2.53 Billion CNY	0.0%
2019 Q4	2.61 Billion CNY	-1.51%
2018 FY	2.2 Billion CNY	1949.48%
2018 Q4	2.2 Billion CNY	0.0%
2017 FY	107.4 Million CNY	0.0%

Peer Total Assets Comparison of InnoCare Pharma Limited

Name	Total Assets	Total Assets Difference
Uni-Bio Science Group Limited	409.99 Million HKD	-2319.347%
CK Life Sciences Int'l., (Holdings) Inc.	11.24 Billion HKD	11.81%